Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

FDA Supac guidance for ER [Regulatives / Guidelines]

posted by jag009 – NJ, 2018-09-07 22:31 (2422 d 20:26 ago) – Posting: # 19251
Views: 2,904

Hi,

Question. To support SUPAC (post approval manufacturing site change) filing for ER products, do we need to perform multimedia dissolution testings?

Thanks
John

Complete thread:

FDA Supac guidance for ERjag009 2018-09-07 20:31 [Regulatives / Guidelines]
- FDA Supac guidance for ER Helmut 2018-09-09 14:04
  - FDA Supac guidance for ER jag009 2018-09-10 18:38

Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
20 visitors (0 registered, 20 guests [including 1 identified bots]).
Forum time: 18:58 CEST (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report. Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz